Keywords: andrx, files, nda, new, lovastatin, form, group

Andrx files NDA for new lovastatin form

Article | 05 April 2001

Andrx Group has submitted its first New Drug Application to the US Foodand Drug Administration for a long-acting version of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in